window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Advanced Therapies
  • Biotech & Pharma Business
  • Central Nervous System
  • Clinical & Regulatory
  • Digital & Data
  • Drug Delivery & Formulation
  • Drug Discovery & Development
  • Genomics and sequencing
  • Manufacturing & Supply Chain
  • Medical devices
  • Opinion & Events
  • Pharmaceuticals and therapeutics
  • Research & Development
  • Therapeutic Areas
  • Uncategorised
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    AMR Action Fund leads €18M Series A for Telum Therapeutics

    read more
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Inocras and AimedBio partner on whole genome sequencing for ADC trials

    read more
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Research & Development

    Icosagen completes €45M biologics manufacturing expansion

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Poolbeg secures South African patent for POLB 001

    read more
  • Advanced Therapies,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Lonza expands HPAPI capacity to support ADC manufacturing

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Inaqovi combination wins EU approval for AML treatment

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Grifols doses first patient in Phase 3 alpha-1 therapy trial

    read more
  • Drug Discovery & Development,Manufacturing & Supply Chain,Research & Development

    Genoskin expands US production of primary human mast cells

    read more
  • Clinical & Regulatory,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    ten23 health secures Swissmedic ATMP manufacturing licences

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Resalis doses first participant in Phase 1b obesity trial

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Hemab advances bleeding disorder pipeline with new clinical and preclinical data at ISTH 2026

    read more
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Elixirgen signs worldwide option deal with Nippon Shinyaku for Duchenne therapy

    read more
  • Clinical & Regulatory,Research & Development,Therapeutic Areas

    Hearing aids linked to lower dementia risk in adults with epilepsy

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Cereno reports positive 12-month CS1 safety data ahead of Phase 2b PAH trial

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    BridgeBio Phase 3 achondroplasia trial published in NEJM

    read more
  • Biotech & Pharma Business,Drug Discovery & Development,Research & Development

    BioInnovation Institute expands into UK with London cardiometabolic innovation hub

    read more
Previous456Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • En Carta Diagnostics secures €5M to advance at-home molecular testing
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Medical devices, Research & Development
  • Theranica expands Nerivio migraine device coverage to more than half of insured Americans
    Categories: Clinical & Regulatory, Medical devices, Pharmaceuticals and therapeutics, Therapeutic Areas
  • mRNA therapy shows potential for treating autoimmune diseases
    Categories: Drug Discovery & Development, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top